🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10257+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10257 recruiting trials

NARecruitingNCT07248254

Effects Of DPPT On Motor Skills And Sleep In Children With Autism

👨‍⚕️ AIZA ZAMIR, MS-PT, Riphah International University📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07459816

Genomic of CONgenital Sideroblastic Anemias

🏥 Centre Hospitalier Universitaire, Amiens📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT06934967

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 12 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07428863

Effects of Jump Rope on Navicular Drop in Down Syndrome

👨‍⚕️ Adil Munir, MS-PT, Study Principal Investigator Riphah International University📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07037420

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

🏥 Alexion Pharmaceuticals, Inc.📍 45 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07428902

Effects Of French Method With/Without Brace In Clubfoot Treatment

👨‍⚕️ Shama Khizar, MSPT, Riphah International University📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07248748

Effects of Alexander Technique in Children With Upper Cross Syndrome.

👨‍⚕️ Shanza Chaudhary, MS-PT, Riphah International University📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06701656

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

🏥 PPD Development, LP📍 36 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07199569

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

🏥 Bavarian Nordic📍 10 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT06176690

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

👨‍⚕️ Premal Lulla, MD, Baylor College of Medicine📍 2 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07359690

Multimodal Analysis of Endomyocardial Biopsies

👨‍⚕️ Lars Michel, PD Dr. med., Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Germany📍 1 site📅 Started Oct 2025View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT07226297

Personalized Antisense Oligonucleotide for A Single Participant With GARS1 Gene Mutation Associated With Charcot-Marie-Tooth Disease Type 2D (CMT2D)

🏥 n-Lorem Foundation📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07223034

A Study of 177Lu-PSMA-617 in People With Gliomas

👨‍⚕️ Brandon Imber, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Oct 2025View details ↗
RecruitingNCT07245407

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

👨‍⚕️ Jinfu Xu, Doctor, Shanghai Tongji Hospital, Tongji University School of Medicine📍 38 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06351345

129 Xenon Imaging in Patients Treated With Sotatercept

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke University📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06809803

Extended-release Sodium Oxybate in Children

👨‍⚕️ Oliver Sum-Ping, MD, Stanford University📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06599697

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

👨‍⚕️ James Andrews, MD, University of Alabama at Birmingham📍 5 sites📅 Started Oct 2025View details ↗
RecruitingNCT07416461

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease

👨‍⚕️ Octavie Lunguya, Institut National de Recherche Biomedicale📍 1 site📅 Started Oct 2025View details ↗
Phase 2, PHASE3RecruitingNCT07499700

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

👨‍⚕️ hui Ming Zhao, Peking University First Hospital📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07007962

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

🏥 Sanofi📍 10 sites📅 Started Oct 2025View details ↗
← PreviousPage 52 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →